The Breast Cancer Alliance Young Investigator Grants fund innovative early-career research in breast cancer, prioritizing novel therapies, diagnostics, liquid biopsy, and radiation approaches.
Funder: Breast Cancer Alliance
Due Dates: March 31, 2026 (Letter of Intent) | August 31, 2026 (Full application, by invitation only)
Funding Amounts: $125,000 total over two years (salary + project costs; indirect costs capped at 8% of direct costs)
Summary: Two-year grants supporting early-career researchers for innovative, independent breast cancer research projects.
Key Information: Only one LOI per institution (YIG or XP) per cycle; U.S. non-profit institutions only.
The Young Investigator Grants (YIG) from the Breast Cancer Alliance (BCA) provide two-year funding to early-career clinical doctors and research scientists to advance innovative, independent breast cancer research projects. The program is designed to help researchers generate preliminary data and establish their careers, especially those who have not yet received major federal funding. Projects may focus on novel therapeutic strategies, diagnostic/prognostic tools, liquid biopsy, or innovative radiation therapy approaches. Awardees receive both salary support and project costs, with a strong emphasis on transparency, reporting, and engagement with the BCA.